Page last updated: 2024-10-16

adenine and Chronic Kidney Failure

adenine has been researched along with Chronic Kidney Failure in 147 studies

Research Excerpts

ExcerptRelevanceReference
"This study investigated whether quercetin could alleviate vascular calcification in experimental chronic renal failure rats induced by adenine."7.85Quercetin Attenuates Vascular Calcification through Suppressed Oxidative Stress in Adenine-Induced Chronic Renal Failure Rats. ( Chang, XY; Cui, L; Hao, LR; Wang, XZ; Zhang, L; Zhou, XR; Zhu, D, 2017)
"While body weight was decreased, kidney weight increased in DEP+adenine versus saline+adenine or DEP."7.83Prolonged Pulmonary Exposure to Diesel Exhaust Particles Exacerbates Renal Oxidative Stress, Inflammation and DNA Damage in Mice with Adenine-Induced Chronic Renal Failure. ( Ali, BH; Beegam, S; Hamadi, NK; Karaca, T; Nemmar, A; Yasin, J; Yuvaraju, P, 2016)
"In order to evaluate the efficacy, and explore the mechanism of SDG to inhibit the progression of renal fibrosis, study was carried out using the adenine-induced Wister rats as the CRF model, and losartan as postive control drug."7.80Chinese herbal medicine Shenqi Detoxification Granule inhibits fibrosis in adenine induced chronic renal failure rats. ( Cai, P; Ma, H; Meng, H; Peng, M; Si, G; Xu, Y; Zhang, X, 2014)
"Metanephros transplantation significantly reduced vascular calcium and phosphorus content and suppressed the progression of vascular calcification as indicated by von Kossa staining of the media of the thoracic aorta."7.78Metanephros transplantation inhibits the progression of vascular calcification in rats with adenine-induced renal failure. ( Hosoya, T; Kawamura, T; Matsumoto, K; Ohkido, I; Utsunomiya, Y; Yokoo, T; Yokote, S, 2012)
"Lamivudine is a safe, effective treatment for hepatitis B virus (HBV) reactivation after renal transplantation."7.73Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection. ( Ceballos, M; Diaz, F; Garcia, A; Garcia, T; González, P; Mazuecos, A; Rivero, M, 2005)
" These results have demonstrated that oral dosing with adenine at 50 mg/kg for 28 days is suitable to induce a stable anemia associated with CKD in mice."5.48A novel approach to adenine-induced chronic kidney disease associated anemia in rodents. ( Hitomi, H; Kitada, K; Nakano, D; Nishiyama, A; Rahman, A; Sufiun, A; Yamazaki, D, 2018)
"But, treatment with diosgenin at a dose of 10, 20, and 40 mg/kg given via oral gavages causes reversion of all the above events in a dose-dependent manner."5.39Diosgenin attenuates vascular calcification in chronic renal failure rats. ( Arunagiri, P; Balamurugan, E; Barathkumar, TR; Manivannan, J; Raja, B; Sivasubramanian, J, 2013)
"We performed a cohort study of 290 chronic hepatitis B patients: 145 patients treated with 10 mg ADV and 145 patients unexposed to ADV at two community clinics, who were matched for age (+/-10 years), sex, and baseline eGFR."5.35Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. ( Garcia, RT; Ha, NB; Levitt, BS; Nguyen, HA; Nguyen, KK; Nguyen, MH; Trinh, HN; Vu, AA, 2009)
"SKI protected against adenine-induced kidney injury and fibrosis and exerted anti-inflammatory, and antioxidant effects in CRF rats."4.12Protective effect and mechanism of Shenkang injection on adenine-induced chronic renal failure in rats. ( Chen, R; Sun, G; Sun, X; Xu, L; Zeng, W; Zhang, X, 2022)
" Here, we established a rat model with secondary hyperparathyroidism (SHPT) and bone disease induced by adenine and a high phosphorous diet and analyzed the skeletal characteristics."3.88A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet. ( Chen, Q; Liu, BC; Lv, LL; Ni, HF; Ni, LH; Song, KY; Tang, RN; Wang, B; Wang, FM; Wang, LT; Wu, M, 2018)
"This study investigated whether quercetin could alleviate vascular calcification in experimental chronic renal failure rats induced by adenine."3.85Quercetin Attenuates Vascular Calcification through Suppressed Oxidative Stress in Adenine-Induced Chronic Renal Failure Rats. ( Chang, XY; Cui, L; Hao, LR; Wang, XZ; Zhang, L; Zhou, XR; Zhu, D, 2017)
"While body weight was decreased, kidney weight increased in DEP+adenine versus saline+adenine or DEP."3.83Prolonged Pulmonary Exposure to Diesel Exhaust Particles Exacerbates Renal Oxidative Stress, Inflammation and DNA Damage in Mice with Adenine-Induced Chronic Renal Failure. ( Ali, BH; Beegam, S; Hamadi, NK; Karaca, T; Nemmar, A; Yasin, J; Yuvaraju, P, 2016)
"In order to evaluate the efficacy, and explore the mechanism of SDG to inhibit the progression of renal fibrosis, study was carried out using the adenine-induced Wister rats as the CRF model, and losartan as postive control drug."3.80Chinese herbal medicine Shenqi Detoxification Granule inhibits fibrosis in adenine induced chronic renal failure rats. ( Cai, P; Ma, H; Meng, H; Peng, M; Si, G; Xu, Y; Zhang, X, 2014)
"Cox proportional hazards and marginal structural models evaluated associations between tenofovir and time to first occurrence of proteinuria (two consecutive urine dipstick measurements ≥30 mg/dl), rapid decline in kidney function (≥3 ml/min per 1."3.78Association of tenofovir exposure with kidney disease risk in HIV infection. ( Choi, AI; Deeks, SG; Estrella, M; Grunfeld, C; Li, Y; Scherzer, R; Shlipak, MG, 2012)
"Metanephros transplantation significantly reduced vascular calcium and phosphorus content and suppressed the progression of vascular calcification as indicated by von Kossa staining of the media of the thoracic aorta."3.78Metanephros transplantation inhibits the progression of vascular calcification in rats with adenine-induced renal failure. ( Hosoya, T; Kawamura, T; Matsumoto, K; Ohkido, I; Utsunomiya, Y; Yokoo, T; Yokote, S, 2012)
" Uremia-related medial calcification was induced by feeding rats an adenine low-protein diet for 4 weeks."3.76Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. ( D'Haese, PC; Dauwe, S; De Broe, ME; De Schutter, T; Neven, E; Persy, V, 2010)
"Lamivudine is a safe, effective treatment for hepatitis B virus (HBV) reactivation after renal transplantation."3.73Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection. ( Ceballos, M; Diaz, F; Garcia, A; Garcia, T; González, P; Mazuecos, A; Rivero, M, 2005)
"Acute renal failure is common in HIV-infected patients and is associated with acute infection and medication-related nephrotoxicity."2.44HIV-1 infection and the kidney: an evolving challenge in HIV medicine. ( de Silva, TI; Dockrell, DH; Griffin, MD; Post, FA, 2007)
"Secondary hyperparathyroidism is a complication of chronic renal failure that is associated with cardiovascular disease."1.62Parathyroid Hormone Induces Transition of Myofibroblasts in Arteriovenous Fistula and Increases Maturation Failure. ( Chen, CH; Chen, CY; Hsieh, HL; Hsu, SC; Huang, PH; Lin, FY; Liu, CT; Shih, CM; Shiu, YT; Sue, YM, 2021)
"To address the issues, a mice model of Chronic renal failure (CRF) was established by gavage 0."1.56Ameliorate effects of soybean soluble polysaccharide on adenine-induced chronic renal failure in mice. ( Hou, G; Huang, Q; Jin, M; Ye, M; Ye, Z; Zhang, X, 2020)
"Fractures averted, cases of ESRD averted, quality-adjusted life-years (QALYs) saved, costs, incremental cost-effectiveness ratios (ICERs), and maximum justifiable price for F/TAF compared with generic F/TDF."1.56Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis. ( Freedberg, KA; Horn, T; McCann, NC; Paltiel, AD; Walensky, RP, 2020)
"Vascular calcification is highly prevalent in end-stage renal diseases and is predictive of cardiovascular events and mortality."1.51Poly(ADP-ribose) polymerase 1 accelerates vascular calcification by upregulating Runx2. ( An, J; Huang, K; Li, Y; Liang, M; Tong, Q; Wang, C; Xu, W; Zhang, F, 2019)
"Kidney fibrosis was associated with upregulation of 6-keto-PGI2/TXB2 in the rat kidney tissue."1.51Comparison of the Effects of Indobufen and Warfarin in a Rat Model of Adenine-Induced Chronic Kidney Disease. ( Gong, J; He, Q; Jin, J; Li, Y; Lou, X; Zhao, L, 2019)
" When CCP dosage reached 200mg/kg/day, the area of renal pathological damage was decreased by 59."1.48Renoprotective effect of Chinese chive polysaccharides in adenine-induced chronic renal failure. ( Chena, HR; Li, QM; Lu, CQ; Luo, JP; Pan, LH; Zha, XQ, 2018)
" These results have demonstrated that oral dosing with adenine at 50 mg/kg for 28 days is suitable to induce a stable anemia associated with CKD in mice."1.48A novel approach to adenine-induced chronic kidney disease associated anemia in rodents. ( Hitomi, H; Kitada, K; Nakano, D; Nishiyama, A; Rahman, A; Sufiun, A; Yamazaki, D, 2018)
"Rats with adenine-induced chronic renal failure (ACRF) develop severe renal insufficiency and metabolic abnormalities that closely resemble those in patients with uremia."1.48Adenine-Induced Chronic Renal Failure in Rats: A Model of Chronic Renocardiac Syndrome with Left Ventricular Diastolic Dysfunction but Preserved Ejection Fraction. ( Guron, CW; Guron, G; Kashioulis, P; Lundgren, J; Nguy, L; Saeed, A; Shubbar, E, 2018)
"ω-3 PUFAs alleviated adenine-induced chronic renal failure through enhancing antioxidant stress and inhibiting inflammatory response via regulating Nrf2 and TGF-β/SMAD pathway."1.48Omega-3 polyunsaturated fatty acids alleviate adenine-induced chronic renal failure via regulating ROS production and TGF-β/SMAD pathway. ( Feng, ZP; Fu, P; Peng, HY; Xu, J, 2018)
"Rats with adenine-induced chronic renal failure (CRF) were prepared by feeding them an adenine-containing diet for four weeks."1.46PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure. ( Kobayashi, M; Takeda, H; Tatemichi, S; Yaguchi, A, 2017)
"In this study, we established a chronic renal failure (CRF) model in rats induced by adenine administration prior to Mg implantation, aiming to predict if CRF patients are suitable for the use of Mg implants."1.43Biodegradable Magnesium (Mg) Implantation Does Not Impose Related Metabolic Disorders in Rats with Chronic Renal Failure. ( Li, Y; Liu, W; Qin, L; Wang, J; Xu, J, 2016)
"Rats with adenine-induced chronic renal failure (A-CRF) develop a reduced rate of relaxation of the thoracic aorta."1.43Adenine-induced chronic renal failure in rats decreases aortic relaxation rate and alters expression of proteins involved in vascular smooth muscle calcium handling. ( Guron, G; Jernås, M; Lundgren, J; Nguy, L; Nilsson, H; Nookaew, I; Olsson, B; Shubbar, E, 2016)
"Subjects with chronic renal failure (CRF) exhibit oxidative genome damage, which may predispose to carcinogenesis, and Gum acacia (GumA) ameliorates this condition in humans and animals."1.42Gum acacia mitigates genetic damage in adenine-induced chronic renal failure in rats. ( Al Balushi, K; Al-Husseini, I; Ali, BH; Mandel, P; Nemmar, A; Ribeiro, DA; Schupp, N, 2015)
"Pathogenesis of adenine-induced chronic renal failure may involve inflammatory, immunological and/or oxidant mechanisms."1.42High-mobility group box-1 protein in adenine-induced chronic renal failure and the influence of gum arabic thereon. ( Al Shukaili, A; Al Za'abi, M; Ali, BH; Nemmar, A, 2015)
"Adenine treatment impaired kidney function: it lowered creatinine clearance and increased plasma concentrations of creatinine, urea, neutrophil gelatinase-associated lipocalin and vanin-1."1.40The effect of activated charcoal on adenine-induced chronic renal failure in rats. ( Al-Lawati, I; Ali, BH; Alza'abi, M; Beegam, S; Brand, S; Nemmar, A; Ramkumar, A; Schupp, N; Waly, MI, 2014)
"Vascular calcification is highly correlated with increased cardiovascular morbidity and mortality."1.40Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro. ( Feng, H; Lei, H; Li, H; Li, L; Wang, C; Wang, JY; Wu, D; Wu, LL; Zhou, Y, 2014)
"The adenine group was subdivided into a model control group (n = 7), a positive control group (200 mg/kg Jinshuibao capsule (JSB; n = 8), and two IF groups (200 mg/kg, n = 8; 100 mg/kg, n = 8)."1.39Nephroprotective effects of Isaria felina in rats with adenine-induced chronic renal failure. ( Bai, X; Ren, L; Yang, X; Zhang, H; Zhang, S, 2013)
"Rats with adenine-induced chronic renal failure (A-CRF) develop metabolic and cardiovascular abnormalities resembling those in patients with chronic kidney disease."1.39Rats with adenine-induced chronic renal failure develop low-renin, salt-sensitive hypertension and increased aortic stiffness. ( Carlström, M; Grimberg, E; Guron, G; Johansson, ME; Lundberg, JO; Lundgren, J; Nguy, L; Nilsson, H; Teerlink, T, 2013)
"After 1 week, rats with chronic renal failure were treated with vehicle, 375 or 750 mg/kg CaMg, or 750 mg/kg sevelamer by daily gavage for 5 weeks."1.39Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. ( Behets, GJ; D'Haese, PC; De Schutter, TM; Geryl, H; Gundlach, K; Neven, E; Passlick-Deetjen, J; Peter, ME; Steppan, S, 2013)
"But, treatment with diosgenin at a dose of 10, 20, and 40 mg/kg given via oral gavages causes reversion of all the above events in a dose-dependent manner."1.39Diosgenin attenuates vascular calcification in chronic renal failure rats. ( Arunagiri, P; Balamurugan, E; Barathkumar, TR; Manivannan, J; Raja, B; Sivasubramanian, J, 2013)
"Acetaminophen has no effect on the progression of renal damage in adenine-induced renal failure model rats."1.38Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats. ( Arimizu, K; Chuang, VT; Hirata, S; Irie, T; Ishitsuka, Y; Kadowaki, D; Kitamura, K; Maruyama, T; Narita, Y; Otagiri, M; Sumikawa, S; Taguchi, K, 2012)
"All three patients progressed to ESRD, within 1 month following renal biopsy in two and after 9 months in one."1.36Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. ( Boelkins, M; Broviac, J; Cornell, LD; Fidler, ME; Milliner, DS; Nasr, SH; Sethi, S, 2010)
"In adenine-induced chronic renal failure rats, the protective effects of these Chinese herbs were of a significant nature."1.36Protection of Chinese herbs against adenine-induced chronic renal failure in rats. ( Guo, H; Han, B; Liu, Y; Tong, Y, 2010)
" When implementing HAART, physicians should be aware of and monitor potential patient misunderstanding of instructions on dosage and administration and for possible complications in medicinal combinations and potential side effects."1.35[A case of acute renal failure involving high amounts of tenofovir after HAART start]. ( Kasahara, K; Konishi, M; Maeda, K; Mikasa, K; Nakagawa, C; Uno, K; Yonekawa, S; Yoshimoto, E, 2008)
"We performed a cohort study of 290 chronic hepatitis B patients: 145 patients treated with 10 mg ADV and 145 patients unexposed to ADV at two community clinics, who were matched for age (+/-10 years), sex, and baseline eGFR."1.35Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. ( Garcia, RT; Ha, NB; Levitt, BS; Nguyen, HA; Nguyen, KK; Nguyen, MH; Trinh, HN; Vu, AA, 2009)
" Third, oral adenine dosing for induction of hyperphosphataemia and validation as a model using Sev were examined."1.35Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model. ( Mizukami, K; Okada, M; Terai, K, 2008)
"However, in chronic renal failure (CRF), serum 1,25(OH)(2)D and Pi levels are often abnormal."1.33Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure. ( Eto, N; Miyata, Y; Ohno, H; Yamashita, T, 2005)
"Adenine-treated rats showed marked elevations of serum phosphorus, PTH and FGF23 levels associated with parathyroid hyperplasia and aortic calcification."1.33[Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease]. ( Abe, M; Kobayashi, N; Miyata, S; Nagano, N; Wada, M; Wakita, S, 2005)
"The adenine-treated rats were divided into the following 3 groups, that is, the group experienced no treatment (control), the group given our Chinese herbal medicine (HAO), and the group given vitamin D3 (VD3) medication."1.33Effects of the Chinese herbal medicine based on Hachimi-jio-gan in male rats with the adenine-induced osteopenia. ( Gao, M; Guo, L; Guo, Y; Ishida, T; Kanehara, M; Ogirima, T; Tano, K; Wang, X; Zhang, Y, 2005)
"The rats with chronic renal failure caused by adenine were divided into 3 groups randomly:the control group (fed with 10 mL water /kg per day), Coated Aldehyde Oxystarch (CAO) group (fed with 20 g CAO /kg and 10 mL water /kg per day) and CLUAs + CAO group (fed with 20 g CAO /kg and 10 mL CLUAs /kg per day) in which CAO was used to absorb the ammonia produced from urea."1.32[The preparation and application of cross-linked urease aggregates]. ( Dong, XY; Xia, SW, 2003)
"The model of chronic renal failure was made by feeding rats with food containing 0."1.30[Effects of Chinese patent medicine tongfugushen on adenine-induced chronic renal failure in rats]. ( Chen, J; Chen, Y; Deng, H; Yu, A, 1999)
"This is the first report of recurrence of the microcrystalline nephritis in a kidney transplant with subsequent loss of allograft function."1.29Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant. ( Daudon, M; Deland, E; Gagné, ER; Nawar, T; Noël, LH, 1994)
"The effect of adenine-induced chronic renal failure on the male reproductive system was studied using male Wistar rats."1.29Reproductive insufficiency in the male rat with adenine-induced chronic renal failure. ( Adachi, Y; Nakada, T; Sasagawa, I, 1993)
"The adenine-fed chronic renal failure group of rats had a reduced renal blood flow of between 30 and 75%, and glomerular filtration rate of approximately 20%, compared to the sham controls."1.28The action of atriopeptin III on renal function in two models of chronic renal failure in the rat. ( Johns, EJ; Rutkowski, B, 1990)
"Methylguanidine (MG) was intraperitoneally administered to both normal rats and those given adenine, and MG levels in the serum, liver, kidney, muscle, brain and urine were compared."1.28Variations in the distribution of methylguanidine with the progression of renal failure after methylguanidine loading. ( Fujitsuka, N; Oura, H; Yokozawa, T, 1989)
" The toxic effects are discussed on the basis of these results."1.28Comparison of toxic effects of methylguanidine, guanidinosuccinic acid and creatinine in rats with adenine-induced chronic renal failure. ( Mo, ZL; Oura, H; Yokozawa, T, 1989)

Research

Studies (147)

TimeframeStudies, this research(%)All Research%
pre-199010 (6.80)18.7374
1990's20 (13.61)18.2507
2000's26 (17.69)29.6817
2010's76 (51.70)24.3611
2020's15 (10.20)2.80

Authors

AuthorsStudies
Ito, S2
Manabe, E1
Dai, Y1
Ishihara, M1
Tsujino, T1
Samynathan, R1
Subramanian, U1
Venkidasamy, B1
Shariati, MA1
Chung, IM1
Thiruvengadam, M1
Chen, R1
Xu, L2
Zhang, X10
Sun, G1
Zeng, W1
Sun, X2
Hamdy, MM1
Abdel-Rahman, MS1
Badary, DM1
Sabra, MS1
Tölle, M1
Henkel, C1
Herrmann, J1
Daniel, C1
Babic, M1
Xia, M1
Schulz, AM1
Amann, K1
van der Giet, M1
Schuchardt, M1
Khattri, RB1
Kim, K1
Anderson, EM1
Fazzone, B1
Harland, KC1
Hu, Q1
Palzkill, VR1
Cort, TA1
O'Malley, KA1
Berceli, SA1
Scali, ST1
Ryan, TE1
Sidman, EF1
Ondrush, NM1
Partosh, D3
Sherman, EM3
Eckardt, PA3
Unger, N3
Montalvo, S3
Sharma, K1
Zhang, G2
Hansen, J1
Bjornstad, P1
Lee, HJ1
Menon, R1
Hejazi, L1
Liu, JJ1
Franzone, A1
Looker, HC1
Choi, BY1
Fernandez, R1
Venkatachalam, MA1
Kugathasan, L1
Sridhar, VS1
Natarajan, L1
Zhang, J5
Sharma, VS1
Kwan, B1
Waikar, SS1
Himmelfarb, J1
Tuttle, KR1
Kestenbaum, B1
Fuhrer, T1
Feldman, HI1
de Boer, IH1
Tucci, FC1
Sedor, J1
Heerspink, HL1
Schaub, J1
Otto, EA1
Hodgin, JB1
Kretzler, M1
Anderton, CR1
Alexandrov, T1
Cherney, D1
Lim, SC1
Nelson, RG1
Gelfond, J1
Iyengar, R1
Drexler, Y1
Fornoni, A1
Hou, G1
Jin, M1
Ye, Z1
Huang, Q1
Ye, M1
Walensky, RP1
Horn, T1
McCann, NC1
Freedberg, KA1
Paltiel, AD1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y4
Wang, J8
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B5
Zhang, Q5
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X7
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J5
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J4
Sun, Q1
Han, D1
Lei, H2
Zhao, K2
Zhu, L1
Li, X5
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J3
Zhang, C3
Chen, L2
Yang, X3
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H6
Yao, L2
Sun, L3
Zhu, Z2
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W3
Gao, S1
Zhai, X1
Wang, C5
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y8
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L5
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X3
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J2
Wu, W1
Liu, Y8
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L2
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S2
Yang, P1
Yu, X2
Wu, Y2
Zhang, H4
Yu, B2
Han, B2
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y3
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L2
Wang, L4
Hu, T1
Wang, F2
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y10
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L2
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W2
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S3
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z3
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y2
Lv, YQ1
Chen, Q2
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C2
Liu, W2
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P2
Atyah, M1
Ma, Q2
Xu, Y3
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M2
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L6
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N2
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X4
Huang, Y2
Josephine Fauci, A1
Ma, Y3
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y3
Huang, M1
Zhu, Y3
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY2
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M2
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F5
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y2
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y2
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y4
Xue, H1
Zhang, W1
Ruan, Z1
Li, S4
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y2
Kong, X1
Lu, J1
Zhang, M2
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J5
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y2
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L2
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J2
Xiao, W3
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C2
Peng, M2
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL2
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Contreras-Salinas, H1
Meza-Rios, A1
García-Bañuelos, J1
Sandoval-Rodriguez, A1
Sanchez-Orozco, L1
García-Benavides, L1
De la Rosa-Bibiano, R1
Monroy Ramirez, HC1
Gutiérrez-Cuevas, J1
Santos-Garcia, A1
Armendariz-Borunda, J1
Feng, Y1
Kong, Y1
Jia, L2
Liu, CT1
Hsu, SC1
Hsieh, HL1
Chen, CH2
Chen, CY1
Sue, YM1
Lin, FY1
Shih, CM1
Shiu, YT1
Huang, PH1
Helber, MJ1
Moore, JE1
Williams, AM1
Meacham, PJ1
Rothberg, PG1
Zent, CS1
Chang, XY1
Cui, L1
Wang, XZ1
Zhu, D2
Zhou, XR1
Hao, LR1
Yaguchi, A1
Tatemichi, S1
Takeda, H1
Kobayashi, M2
Li, QM2
Chena, HR1
Zha, XQ2
Lu, CQ1
Pan, LH2
Luo, JP2
Zhang, CY1
Zhu, JY1
Ye, Y1
Zhang, LJ1
Wang, SJ1
Song, YN1
Tartaglia, A1
Ferrara, SM1
Sica, S1
Santantonio, T1
Cai, H1
Su, S1
Zeng, H1
Guo, J1
Qian, D1
Rahman, A1
Yamazaki, D1
Sufiun, A1
Kitada, K1
Hitomi, H1
Nakano, D1
Nishiyama, A1
Ni, LH1
Tang, RN1
Lv, LL1
Wu, M1
Wang, FM1
Ni, HF1
Song, KY1
Wang, LT1
Liu, BC1
Yao, Z1
Ma, W1
Sun, XY1
Jia, S1
Kashioulis, P1
Lundgren, J4
Shubbar, E2
Nguy, L5
Saeed, A2
Guron, CW1
Guron, G5
Feng, ZP1
Peng, HY1
An, J1
Liang, M1
Zhang, F1
Tong, Q1
Huang, K1
Long, M1
Fang, Q1
Lou, X1
Jin, J1
Gong, J1
He, Q1
Manivannan, J1
Barathkumar, TR1
Sivasubramanian, J1
Arunagiri, P1
Raja, B1
Balamurugan, E1
De Schutter, TM2
Behets, GJ2
Geryl, H1
Peter, ME1
Steppan, S1
Gundlach, K1
Passlick-Deetjen, J1
D'Haese, PC4
Neven, E4
Johansson, ME2
Grimberg, E2
Teerlink, T2
Carlström, M1
Lundberg, JO1
Nilsson, H3
Zhao, YY6
Li, HT1
Bai, X6
Lin, RC6
Imai, E1
Sano, M2
Fukuwatari, T1
Shibata, K1
Phan, O1
Maillard, M1
Peregaux, C1
Mordasini, D1
Stehle, JC1
Funk, F1
Ren, L1
Rasch, MG1
Helleberg, M1
Feldt-Rasmussen, B1
Kronborg, G1
Larsen, CS1
Pedersen, C1
Pedersen, G1
Gerstoft, J1
Obel, N1
Kobayashi, T1
Matsumura, Y1
Ozawa, T1
Yanai, H1
Iwasawa, A1
Kamachi, T1
Fujiwara, K1
Tanaka, N1
Kohno, M1
Ali, BH10
Alza'abi, M1
Ramkumar, A3
Al-Lawati, I2
Waly, MI2
Beegam, S6
Nemmar, A10
Brand, S1
Schupp, N3
DiBona, GF1
Mikkelsen, ML1
Marcussen, N1
Al Za'abi, M4
Yasin, J2
Feng, H1
Wu, D1
Wu, LL1
Cai, P1
Ma, H1
Meng, H1
Si, G1
Inuwa, I1
Al Bahlani, S1
Al Issaei, H1
Madanagopal, T1
Malheiros, DM1
Zatz, R1
Al Shukaili, A1
Zheng, B1
Zhou, PP1
Zhang, RN1
He, M1
Wen, JK1
Yamada, S1
Tatsumoto, N1
Tokumoto, M1
Noguchi, H1
Ooboshi, H1
Kitazono, T1
Tsuruya, K1
Mishima, E1
Fukuda, S1
Shima, H1
Hirayama, A1
Akiyama, Y1
Takeuchi, Y1
Fukuda, NN1
Suzuki, T1
Suzuki, C1
Yuri, A1
Kikuchi, K1
Tomioka, Y1
Soga, T1
Abe, T1
Claramunt, D1
Gil-Peña, H1
Fuente, R1
García-López, E1
Loredo, V1
Hernández-Frías, O1
Ordoñez, FA1
Rodríguez-Suárez, J1
Santos, F1
Al Balushi, K1
Al-Husseini, I1
Mandel, P1
Ribeiro, DA1
Gui, B2
Yao, G1
Fu, R1
Ge, H1
Tian, L1
Duan, Z2
Hou, W1
Lin, Y1
Fu, Y1
Yu, F1
Xu, SS1
Xu, Q1
Guan, Y2
Kong, W2
Karaca, T1
Yuvaraju, P1
Hamadi, NK1
Jia, X1
Pan, J1
Han, Y1
Feng, X1
Qin, L1
Jernås, M1
Nookaew, I1
Olsson, B1
George, SA1
Al-Rushaidan, S1
Francis, I1
Soonowala, D1
Nampoory, MRN1
Mazumder, MK1
Giri, A1
Kumar, S1
Borah, A1
Yoshimoto, E1
Konishi, M1
Uno, K1
Nakagawa, C1
Yonekawa, S1
Kasahara, K1
Maeda, K1
Mikasa, K1
Chen, Y2
Hou, LB3
Campbell, LJ1
Ibrahim, F1
Fisher, M1
Holt, SG1
Hendry, BM1
Post, FA2
Postnov, AA2
De Clerck, NM2
Persy, VP2
Ha, NB2
Garcia, RT1
Trinh, HN1
Vu, AA1
Nguyen, HA1
Nguyen, KK1
Levitt, BS1
Nguyen, MH1
Nasr, SH1
Sethi, S1
Cornell, LD1
Milliner, DS1
Boelkins, M1
Broviac, J1
Fidler, ME1
Li, TT1
Si, GM1
Chen, FC1
Ienaga, K2
Yokozawa, T11
Persy, V1
Dauwe, S1
De Schutter, T1
De Broe, ME1
Mocroft, A2
Kirk, O2
Reiss, P2
De Wit, S1
Sedlacek, D1
Beniowski, M2
Gatell, J2
Phillips, AN1
Ledergerber, B1
Lundgren, JD2
Pang, LL1
Mei, QX1
Kong, XL1
Gao, YQ1
Lin, H1
Liu, ZH1
Zeng, CY1
Lian, YY1
Zhang, ZR1
Goux, A1
Feillet-Coudray, C1
Jover, B1
Fouret, G1
Bargnoux, AS1
Cassan, C1
Richard, S1
Badiou, S1
Cristol, JP1
Ziada, A2
Al Husseni, I2
Francisci, D1
Martinelli, L1
Weimer, LE1
Zazzi, M1
Floridia, M1
Masini, G1
Baldelli, F1
Tong, Y1
Guo, H1
Al-Ruqaishi, B1
Cheng, XL5
Xiao, XY1
Sun, WJ1
Yokote, S1
Yokoo, T1
Matsumoto, K1
Ohkido, I1
Utsunomiya, Y1
Kawamura, T1
Hosoya, T1
Yun, H1
Ando, M1
Tsuchiya, K1
Nitta, K1
Scherzer, R1
Estrella, M1
Choi, AI1
Deeks, SG1
Grunfeld, C1
Shlipak, MG1
Scheffer, PG1
Cui, JH1
Yan, XR1
del Palacio, M1
Romero, S1
Casado, JL1
Fafin, C1
Pugliese, P1
Durant, J1
Mondain, V1
Rahelinirina, V1
De Salvador, F1
Ceppi, C1
Perbost, I1
Rosenthal, E1
Roger, PM1
Cua, E1
Dellamonica, P1
Esnault, V1
Pradier, C1
Moranne, O1
Kadowaki, D1
Sumikawa, S1
Arimizu, K1
Taguchi, K1
Kitamura, K1
Ishitsuka, Y1
Narita, Y1
Irie, T1
Chuang, VT1
Maruyama, T1
Otagiri, M1
Hirata, S1
Long, FY1
Komazawa, H1
Yamaguchi, H1
Hidaka, K1
Ogura, J1
Iseki, K1
Dickman, KG1
Huang, CY1
Moriya, M1
Shun, CT1
Tai, HC1
Huang, KH1
Wang, SM1
Lee, YJ1
Grollman, AP1
Pu, YS1
Dai, XY1
Zhao, MM1
Guan, QC1
Zhu, WG1
Xu, MJ1
Al-Husseni, I1
Al-Shukaili, A1
Schierling, S1
Queisser, N1
Deng, H1
Yu, A1
Izzedine, H1
Launay-Vacher, V1
Jullien, V1
Aymard, G1
Duvivier, C1
Deray, G1
Nakagawa, T1
Takeuchi, S1
Kim, M1
Minamoto, S1
Wang, S1
Fu, Q1
Garcia, A1
Mazuecos, A1
González, P1
Diaz, F1
Garcia, T1
Ceballos, M1
Rivero, M1
Eto, N1
Miyata, Y1
Ohno, H1
Yamashita, T1
Dong, XY1
Xia, SW1
Silva, AC1
Morsch, AL1
Zanin, RF1
Corrêa, MC1
Arantes, LC1
Araujo, MC1
Morsch, VM1
Schetinger, MR1
Nagano, N1
Miyata, S1
Abe, M1
Wakita, S1
Kobayashi, N1
Wada, M1
Ogirima, T1
Tano, K1
Kanehara, M1
Ishida, T1
Pol, S1
Inoue, H1
Nonomura, N1
Kojima, Y1
Shiba, M1
Oka, D1
Arai, Y1
Nakayama, M1
Takayama, H1
Nishimura, K1
Mori, H1
Okuyama, A1
Gargalianos, P1
Zilmer, K1
Viard, JP1
Staszewski, S1
de Silva, TI1
Griffin, MD1
Dockrell, DH1
Hamada, Y1
Kono, TN1
Moriguchi, Y1
Higuchi, M1
Fukagawa, M1
Terai, K1
Mizukami, K1
Okada, M1
Greenwood, MC1
Dillon, MJ1
Simmonds, HA3
Barratt, TM1
Pincott, JR1
Metreweli, C1
Noro, T1
Ogiwara, M1
Okamura, M1
Marlewski, M4
Smolenski, RT5
Swierczynski, J6
Rutkowski, B6
Duley, JA1
Zydowo, MM1
Wang, GZ1
Hikokichi, O1
Gagné, ER1
Deland, E1
Daudon, M1
Noël, LH1
Nawar, T1
Adachi, Y1
Sasagawa, I1
Nakada, T2
Oura, H9
Nakamura, K1
Fye, KH2
Sahota, A1
Hancock, DC2
Gelb, AB2
Sparks, JW2
Sibley, RK2
Tischfield, JA2
Zhou, JX1
Liu, R1
Yang, SX1
Kamatani, N1
Brown, HA1
Laurence, A1
Safranow, K1
Szolkiewicz, M3
Aleksandrowicz, Z1
Kurata, N1
Nakamura, S1
Mizumura, J1
Sumi, M1
Nishimura, Y1
Yamamoto, T1
Yasuhara, H1
Słomińska, E2
Szołkiewicz, M1
Edvardsson, V1
Palsson, R1
Olafsson, I1
Hjaltadottir, G1
Laxdal, T1
Slominska, EM1
Zhang, SG1
Xiong, GL1
Fujioka, K1
Jujioka, K1
Sahota, AS1
Nutahara, K1
Oshi, M1
Higashihara, E1
Chung, HY2
Lee, TW1
Nonaka, G1
Nishioka, I1
Johns, EJ1
Fujitsuka, N1
Mo, ZL1
Glicklich, D1
Gruber, HE1
Matas, AJ1
Tellis, VA1
Karwa, G1
Finley, K1
Salem, C1
Soberman, R1
Seegmiller, JE1
Zheng, PD1
Koizumi, F1
Chang, GN1
Fam, A1
Little, AH1
Malkin, A1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
HBV Viral Suppression by Entecavir in Adefovir Partial Responders[NCT00704106]60 participants (Actual)Observational2008-05-31Completed
EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV[NCT02699736]23,000 participants (Actual)Observational [Patient Registry]1994-01-31Enrolling by invitation
Effectiveness of Chinese Medicine on Deferring Dialysis Initiation for Stage 5 Chronic Kidney Disease[NCT02194946]Phase 1/Phase 2875 participants (Anticipated)Interventional2014-07-31Active, not recruiting
Potential Role of Gum Arabic as Antioxidant and Anti-inflammatory Agent in Hemodialysis Patients[NCT03214692]50 participants (Anticipated)Interventional2017-07-31Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

8 reviews available for adenine and Chronic Kidney Failure

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
How to manage HIV-infected patients with chronic kidney disease in the HAART era.
    Clinical and experimental nephrology, 2012, Volume: 16, Issue:3

    Topics: Adenine; Albuminuria; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black People; Cystatin

2012
The use of biomarkers for assessing HAART-associated renal toxicity in HIV-infected patients.
    Current HIV research, 2012, Volume: 10, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; Biomarkers; Crea

2012
[Impact of resistance to analogue antivirals and therapeutic strategies in situations of dialysis, kidney transplantation, vasculitis, and preemptive treatments in immunosuppressed patients].
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:10 Pt 2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis

2006
HIV-1 infection and the kidney: an evolving challenge in HIV medicine.
    Mayo Clinic proceedings, 2007, Volume: 82, Issue:9

    Topics: Acute Disease; Acute Kidney Injury; Adenine; AIDS-Associated Nephropathy; Angiotensin-Converting Enz

2007
[Adenine phosphoribosyltransferase(APRT) deficiency].
    Nihon rinsho. Japanese journal of clinical medicine, 1996, Volume: 54, Issue:12

    Topics: Adenine; Adenine Phosphoribosyltransferase; Alleles; Allopurinol; Heterozygote; Homozygote; Humans;

1996
[Phosphoribosyltransferase (APRT) deficiency--molecular and clinical aspects of dihydroxyadeninuria].
    Postepy higieny i medycyny doswiadczalnej, 1998, Volume: 52, Issue:1

    Topics: Adenine; Adenine Phosphoribosyltransferase; Humans; Kidney Failure, Chronic; Purine-Pyrimidine Metab

1998
2,8-dihydroxyadenine urolithiasis: report of a case first diagnosed after renal transplant.
    The Quarterly journal of medicine, 1988, Volume: 68, Issue:258

    Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Female; Humans; Kidney Calculi; Kidney Failure, C

1988

Trials

2 trials available for adenine and Chronic Kidney Failure

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
[Renal replacement therapy results in correction of plasma and erythrocyte adenine nucleotide abnormalities in patients with chronic renal failure].
    Polskie Archiwum Medycyny Wewnetrznej, 2001, Volume: 106, Issue:6

    Topics: Adenine; Adenosine Triphosphate; Adult; Aged; Erythrocytes; Erythropoietin; Female; Humans; Kidney F

2001

Other Studies

138 other studies available for adenine and Chronic Kidney Failure

ArticleYear
Juzentaihoto improves adenine-induced chronic renal failure in BALB/c mice via suppression of renal fibrosis and inflammation.
    Journal of pharmacological sciences, 2022, Volume: 148, Issue:1

    Topics: Adenine; Administration, Oral; Animals; Disease Models, Animal; Disease Progression; Drugs, Chinese

2022
S-Allylcysteine (SAC) Exerts Renoprotective Effects via Regulation of TGF- β1/Smad3 Pathway Mediated Matrix Remodeling in Chronic Renal Failure.
    Current pharmaceutical design, 2022, Volume: 28, Issue:8

    Topics: Adenine; Aged; Animals; Cysteine; Fibrosis; Humans; Kidney Failure, Chronic; Rats; Rats, Wistar; Ren

2022
Protective effect and mechanism of Shenkang injection on adenine-induced chronic renal failure in rats.
    Acta cirurgica brasileira, 2022, Volume: 37, Issue:3

    Topics: Adenine; Animals; Drugs, Chinese Herbal; Fibrosis; Kidney; Kidney Failure, Chronic; Rats; Rats, Spra

2022
Effects of furosemide and tadalafil in both conventional and nanoforms against adenine-induced chronic renal failure in rats.
    European journal of medical research, 2022, Jul-11, Volume: 27, Issue:1

    Topics: Adenine; Animals; Caspase 3; Furosemide; Humans; Kidney Failure, Chronic; Rats; Renal Insufficiency,

2022
Uremic mouse model to study vascular calcification and "inflamm-aging".
    Journal of molecular medicine (Berlin, Germany), 2022, Volume: 100, Issue:9

    Topics: Adenine; Aging; Animals; Disease Models, Animal; Inflammation; Kidney Failure, Chronic; Mice; Rats;

2022
Metabolomic profiling reveals muscle metabolic changes following iliac arteriovenous fistula creation in mice.
    American journal of physiology. Renal physiology, 2022, 11-01, Volume: 323, Issue:5

    Topics: Adenine; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Arteriovenous Fistula; Arterioven

2022
Utilization of bictegravir/emtricitabine/tenofovir alafenamide in patients with end-stage renal disease on hemodialysis.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2023, 04-19, Volume: 80, Issue:9

    Topics: Adenine; Anti-HIV Agents; Drug Combinations; Emtricitabine; Heterocyclic Compounds, 3-Ring; Heterocy

2023
Bictegravir/emtricitabine/tenofovir alafenamide in a virologically suppressed adult with HIV and end-stage renal disease on chronic peritoneal dialysis: A case report.
    International journal of STD & AIDS, 2023, Volume: 34, Issue:2

    Topics: Adenine; Adult; Anti-HIV Agents; Drug Combinations; Emtricitabine; HIV Infections; Humans; Kidney Fa

2023
Bictegravir/emtricitabine/tenofovir alafenamide in a virologically suppressed adult with HIV and end-stage renal disease on chronic peritoneal dialysis: A case report.
    International journal of STD & AIDS, 2023, Volume: 34, Issue:2

    Topics: Adenine; Adult; Anti-HIV Agents; Drug Combinations; Emtricitabine; HIV Infections; Humans; Kidney Fa

2023
Bictegravir/emtricitabine/tenofovir alafenamide in a virologically suppressed adult with HIV and end-stage renal disease on chronic peritoneal dialysis: A case report.
    International journal of STD & AIDS, 2023, Volume: 34, Issue:2

    Topics: Adenine; Adult; Anti-HIV Agents; Drug Combinations; Emtricitabine; HIV Infections; Humans; Kidney Fa

2023
Bictegravir/emtricitabine/tenofovir alafenamide in a virologically suppressed adult with HIV and end-stage renal disease on chronic peritoneal dialysis: A case report.
    International journal of STD & AIDS, 2023, Volume: 34, Issue:2

    Topics: Adenine; Adult; Anti-HIV Agents; Drug Combinations; Emtricitabine; HIV Infections; Humans; Kidney Fa

2023
Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients.
    The Journal of clinical investigation, 2023, 10-16, Volume: 133, Issue:20

    Topics: Adenine; Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic N

2023
Adenine crosses the biomarker bridge: from 'omics to treatment in diabetic kidney disease.
    The Journal of clinical investigation, 2023, 10-16, Volume: 133, Issue:20

    Topics: Adenine; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Kidney Failu

2023
Ameliorate effects of soybean soluble polysaccharide on adenine-induced chronic renal failure in mice.
    International journal of biological macromolecules, 2020, Apr-15, Volume: 149

    Topics: Adenine; Animals; Glycine max; Kidney Failure, Chronic; Male; Mice; Polysaccharides

2020
Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.
    Annals of internal medicine, 2020, 05-05, Volume: 172, Issue:9

    Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Cost-Benefit Analysis; Drugs, Generic; Emtricitabine; F

2020
Fibrosis regression is induced by AdhMMP8 in a murine model of chronic kidney injury.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Adenine; Adenoviridae; Animals; Disease Models, Animal; Fibrosis; Gene Expression Regulation; HEK293

2020
Antioxidation, anti-inflammation and anti-fibrosis effect of phosphorylated polysaccharides from Pleurotus djamor mycelia on adenine-induced chronic renal failure mice.
    International journal of biological macromolecules, 2021, Feb-15, Volume: 170

    Topics: Adenine; Animals; Anti-Inflammatory Agents; Antioxidants; Dietary Supplements; Disease Models, Anima

2021
Parathyroid Hormone Induces Transition of Myofibroblasts in Arteriovenous Fistula and Increases Maturation Failure.
    Endocrinology, 2021, 07-01, Volume: 162, Issue:7

    Topics: Adenine; Aged; Animals; Arteriovenous Shunt, Surgical; Biomarkers; Cell Culture Techniques; Disease

2021
Ibrutinib therapy for lymphoplasmacytic lymphoma.
    American journal of hematology, 2017, Volume: 92, Issue:9

    Topics: Adenine; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Antineoplastic Agents;

2017
Quercetin Attenuates Vascular Calcification through Suppressed Oxidative Stress in Adenine-Induced Chronic Renal Failure Rats.
    BioMed research international, 2017, Volume: 2017

    Topics: Adenine; Alkaline Phosphatase; Animals; Aorta; Biomarkers; Calcium; Kidney; Kidney Failure, Chronic;

2017
PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Adenine; Animals; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Models, Animal; Dose-Res

2017
Renoprotective effect of Chinese chive polysaccharides in adenine-induced chronic renal failure.
    International journal of biological macromolecules, 2018, Volume: 106

    Topics: Adenine; Animals; Antioxidants; Blood Urea Nitrogen; Chive; Creatinine; Humans; Inflammation; Kidney

2018
Erhuang Formula ameliorates renal damage in adenine-induced chronic renal failure rats via inhibiting inflammatory and fibrotic responses.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 95

    Topics: Adenine; Animals; Blood Urea Nitrogen; Chromatography, High Pressure Liquid; Creatinine; Drugs, Chin

2017
Successful treatment with tenofovir alafenamide of a HIV/hepatitis B virus coinfected patient with HIV and hepatitis B virus drug resistance, end-stage renal disease on haemodialysis.
    AIDS (London, England), 2017, 10-23, Volume: 31, Issue:16

    Topics: Adenine; Adult; Alanine; Antiviral Agents; Coinfection; Drug Resistance, Viral; Female; Hepatitis B,

2017
Protective effects of Salvia miltiorrhiza on adenine-induced chronic renal failure by regulating the metabolic profiling and modulating the NADPH oxidase/ROS/ERK and TGF-β/Smad signaling pathways.
    Journal of ethnopharmacology, 2018, Feb-15, Volume: 212

    Topics: Adenine; Animals; Biomarkers; Cell Line; Extracellular Signal-Regulated MAP Kinases; Gene Expression

2018
A novel approach to adenine-induced chronic kidney disease associated anemia in rodents.
    PloS one, 2018, Volume: 13, Issue:2

    Topics: Adenine; Anemia; Animals; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Erythro

2018
A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
    Biochemical and biophysical research communications, 2018, 04-06, Volume: 498, Issue:3

    Topics: Adenine; Animals; Bone and Bones; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Diet; Disea

2018
Magnesium Citrate Protects Against Vascular Calcification in an Adenine-induced Chronic Renal Failure Rat Model.
    Journal of cardiovascular pharmacology, 2018, Volume: 72, Issue:6

    Topics: Actins; Adenine; Alkaline Phosphatase; Animals; Aorta; Aortic Diseases; Calcium; Cardiovascular Agen

2018
Adenine-Induced Chronic Renal Failure in Rats: A Model of Chronic Renocardiac Syndrome with Left Ventricular Diastolic Dysfunction but Preserved Ejection Fraction.
    Kidney & blood pressure research, 2018, Volume: 43, Issue:4

    Topics: Adenine; Animals; Apoptosis; Cardio-Renal Syndrome; Disease Models, Animal; Heart Failure, Diastolic

2018
Omega-3 polyunsaturated fatty acids alleviate adenine-induced chronic renal failure via regulating ROS production and TGF-β/SMAD pathway.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:15

    Topics: Adenine; Animals; Blood Urea Nitrogen; Creatinine; Fatty Acids, Omega-3; Glutathione; Kidney; Kidney

2018
Poly(ADP-ribose) polymerase 1 accelerates vascular calcification by upregulating Runx2.
    Nature communications, 2019, 03-13, Volume: 10, Issue:1

    Topics: Adenine; Animals; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Gene

2019
Renoprotective Effect of
    Molecules (Basel, Switzerland), 2019, Apr-16, Volume: 24, Issue:8

    Topics: Adenine; Animals; Body Weight; Disease Models, Animal; Kidney Failure, Chronic; Laminaria; Male; Mic

2019
Comparison of the Effects of Indobufen and Warfarin in a Rat Model of Adenine-Induced Chronic Kidney Disease.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, May-14, Volume: 25

    Topics: Adenine; Animals; Anticoagulants; China; Disease Models, Animal; Fibrosis; Isoindoles; Kidney; Kidne

2019
Diosgenin attenuates vascular calcification in chronic renal failure rats.
    Molecular and cellular biochemistry, 2013, Volume: 378, Issue:1-2

    Topics: Adenine; Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Aorta; Biomarkers; Calcium; Catala

2013
Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
    Kidney international, 2013, Volume: 83, Issue:6

    Topics: Acetates; Adenine; Animals; Aortic Diseases; Bone Morphogenetic Protein 2; Calcium; Calcium Compound

2013
Rats with adenine-induced chronic renal failure develop low-renin, salt-sensitive hypertension and increased aortic stiffness.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2013, May-01, Volume: 304, Issue:9

    Topics: Adenine; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Arterial Pressure; Benzimidazoles;

2013
Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats.
    Journal of ethnopharmacology, 2013, Jul-09, Volume: 148, Issue:2

    Topics: Adenine; Animals; Biomarkers; Chromatography, High Pressure Liquid; Cocos; Diuretics; Drugs, Chinese

2013
Changes in B-group vitamin status in adenine-induced chronic renal failure rats.
    Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:5

    Topics: Adenine; Animals; Diet; Kidney Failure, Chronic; Male; Organ Specificity; Rats; Rats, Wistar; Vitami

2013
PA21, a new iron-based noncalcium phosphate binder, prevents vascular calcification in chronic renal failure rats.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 346, Issue:2

    Topics: Adenine; Animals; Aorta; Blood Pressure; Calcium; Calcium Carbonate; Ferric Compounds; Fibroblast Gr

2013
Nephroprotective effects of Isaria felina in rats with adenine-induced chronic renal failure.
    The Journal of pharmacy and pharmacology, 2013, Volume: 65, Issue:9

    Topics: Adenine; Animals; Ascomycota; Biological Products; Blood Urea Nitrogen; Cordyceps; Creatinine; Disea

2013
Increased risk of dialysis and end-stage renal disease among HIV patients in Denmark compared with the background population.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:6

    Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Cohort Studies; Comorbidity; Denmark; Female; H

2014
Exploration of novel predictive markers in rat plasma of the early stages of chronic renal failure.
    Analytical and bioanalytical chemistry, 2014, Volume: 406, Issue:5

    Topics: Adenine; Adenosine; Animals; Biomarkers; Chromatography, Liquid; Cresols; Early Diagnosis; Glycochol

2014
The effect of activated charcoal on adenine-induced chronic renal failure in rats.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014, Volume: 65

    Topics: Adenine; Animals; Body Weight; Charcoal; Kidney Failure, Chronic; Male; Organ Size; Rats; Rats, Wist

2014
High-NaCl diet impairs dynamic renal blood flow autoregulation in rats with adenine-induced chronic renal failure.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2014, Mar-15, Volume: 306, Issue:6

    Topics: Adenine; Animals; Baroreflex; Blood Pressure; Glomerular Filtration Rate; Heart Rate; Hemodynamics;

2014
Anemia in adenine-induced chronic renal failure and the influence of treatment with gum acacia thereon.
    Physiological research, 2014, Volume: 63, Issue:3

    Topics: Adenine; Anemia; Animals; Gum Arabic; Kidney Failure, Chronic; Male; Phytotherapy; Random Allocation

2014
Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:5

    Topics: Actins; Adenine; Alkaline Phosphatase; Animals; Aorta, Abdominal; Aortic Diseases; Bone Morphogeneti

2014
Chinese herbal medicine Shenqi Detoxification Granule inhibits fibrosis in adenine induced chronic renal failure rats.
    African journal of traditional, complementary, and alternative medicines : AJTCAM, 2014, Volume: 11, Issue:1

    Topics: Adenine; Albumins; Animals; Blood Urea Nitrogen; Cholesterol; Connective Tissue Growth Factor; Creat

2014
Renal and myocardial histopathology and morphometry in rats with adenine - induced chronic renal failure: influence of gum acacia.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2014, Volume: 34, Issue:3

    Topics: Adenine; Animals; Body Weight; Gum Arabic; Kidney; Kidney Failure, Chronic; Male; Myocardium; Organ

2014
High-mobility group box-1 protein in adenine-induced chronic renal failure and the influence of gum arabic thereon.
    Physiological research, 2015, Volume: 64, Issue:1

    Topics: Adenine; Animals; Biomarkers; Creatinine; Disease Models, Animal; Gum Arabic; HMGB1 Protein; Indican

2015
Vascular calcification is coupled with phenotypic conversion of vascular smooth muscle cells through Klf5-mediated transactivation of the Runx2 promoter.
    Bioscience reports, 2014, Nov-04, Volume: 34, Issue:6

    Topics: Adenine; Animals; Blotting, Western; Calcinosis; Cells, Cultured; Core Binding Factor Alpha 1 Subuni

2014
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
    Calcified tissue international, 2015, Volume: 96, Issue:4

    Topics: Adenine; Animal Feed; Animals; Calcinosis; Calcium Carbonate; Cellular Senescence; Disease Models, A

2015
Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.
    Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:8

    Topics: Adenine; Alprostadil; Animals; Chloride Channel Agonists; Disease Progression; Drug Evaluation, Prec

2015
Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia.
    American journal of physiology. Renal physiology, 2015, Jul-01, Volume: 309, Issue:1

    Topics: Adenine; Animals; Disease Models, Animal; Female; Growth; Growth Disorders; Growth Plate; Kidney; Ki

2015
Gum acacia mitigates genetic damage in adenine-induced chronic renal failure in rats.
    European journal of clinical investigation, 2015, Volume: 45, Issue:12

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenine; Animals; Comet Assay; Deoxyguanosine; DNA Damage; Guanine; Gua

2015
Citrate Attenuates Adenine-Induced Chronic Renal Failure in Rats by Modulating the Th17/Treg Cell Balance.
    Inflammation, 2016, Volume: 39, Issue:1

    Topics: Adenine; Animals; Anti-Inflammatory Agents; Blood Urea Nitrogen; Cell Survival; Citric Acid; Creatin

2016
Sodium Citrate Inhibits Endoplasmic Reticulum Stress in Rats with Adenine-Induced Chronic Renal Failure.
    American journal of nephrology, 2015, Volume: 42, Issue:1

    Topics: Activating Transcription Factor 6; Adenine; Animals; Blood Urea Nitrogen; Buffers; Citrates; Collage

2015
Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:1

    Topics: Adenine; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Calcitriol; Cells, Cultured; C

2016
Prolonged Pulmonary Exposure to Diesel Exhaust Particles Exacerbates Renal Oxidative Stress, Inflammation and DNA Damage in Mice with Adenine-Induced Chronic Renal Failure.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 38, Issue:5

    Topics: Adenine; Animals; Antioxidants; Blood Pressure; Body Weight; Catalase; Creatinine; DNA Damage; Femal

2016
Bone marrow mesenchymal stromal cells ameliorate angiogenesis and renal damage via promoting PI3k-Akt signaling pathway activation in vivo.
    Cytotherapy, 2016, Volume: 18, Issue:7

    Topics: Adenine; Animals; Bone Marrow Cells; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney

2016
Biodegradable Magnesium (Mg) Implantation Does Not Impose Related Metabolic Disorders in Rats with Chronic Renal Failure.
    Scientific reports, 2016, 05-23, Volume: 6

    Topics: Absorbable Implants; Adenine; Animals; Disease Models, Animal; Kidney; Kidney Failure, Chronic; Live

2016
Adenine-induced chronic renal failure in rats decreases aortic relaxation rate and alters expression of proteins involved in vascular smooth muscle calcium handling.
    Acta physiologica (Oxford, England), 2016, Volume: 218, Issue:4

    Topics: Adenine; Animals; Aorta, Thoracic; Blotting, Western; Calcium; Disease Models, Animal; Kidney Failur

2016
2,8-Dihydroxyadenine Nephropathy Identified as Cause of End-Stage Renal Disease After Renal Transplant.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2017, Volume: 15, Issue:5

    Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Allopurinol; Biomarkers; Biopsy; Enzyme Inhibitor

2017
A highly reproducible mice model of chronic kidney disease: Evidences of behavioural abnormalities and blood-brain barrier disruption.
    Life sciences, 2016, Sep-15, Volume: 161

    Topics: Adenine; Animals; Behavior, Animal; Blood-Brain Barrier; Brain; Creatinine; Diet; Disease Models, An

2016
[A case of acute renal failure involving high amounts of tenofovir after HAART start].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2008, Volume: 82, Issue:6

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Kidney Fail

2008
[Effect of shenshuaining dispersible tablets on the levels of NO, NOS, SOD and MDA in kidney of chronic renal failure rats].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2008, Volume: 31, Issue:8

    Topics: Adenine; Animals; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Female; Kidney;

2008
Spectrum of chronic kidney disease in HIV-infected patients.
    HIV medicine, 2009, Volume: 10, Issue:6

    Topics: Adenine; Adult; Age Factors; AIDS-Associated Nephropathy; Analysis of Variance; Anti-HIV Agents; Fem

2009
Possibilities and limits of X-ray microtomography for in vivo and ex vivo detection of vascular calcifications.
    The international journal of cardiovascular imaging, 2009, Volume: 25, Issue:6

    Topics: Adenine; Animals; Aorta; Aortic Diseases; Aortography; Calcinosis; Calcium; Disease Models, Animal;

2009
Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil.
    Hepatology (Baltimore, Md.), 2009, Volume: 50, Issue:3

    Topics: Adenine; Adult; Aged; Antiviral Agents; Cohort Studies; Creatinine; Female; Glomerular Filtration Ra

2009
Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:6

    Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Allopurinol; Crystallization; Diagnosis, Differen

2010
[Effects of Shenqi Jiedu Decoction on expressions of transforming growth factor-beta1, smad2 and smad3 in renal tissues of rats with chronic renal failure induced by adenine].
    Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2010, Volume: 8, Issue:3

    Topics: Adenine; Animals; Drugs, Chinese Herbal; Kidney Failure, Chronic; Male; Phytotherapy; Rats; Rats, Wi

2010
Treatment with NZ-419 (5-Hydroxy-1-methylimidazoline-2,4-dione), a novel intrinsic antioxidant, against the progression of chronic kidney disease at stages 3 and 4 in rats.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:5

    Topics: Adenine; Administration, Oral; Animals; Antioxidants; Creatinine; Disease Models, Animal; Disease Pr

2010
Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats.
    Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:9

    Topics: Adenine; Animals; Aortic Diseases; Biomarkers; Calcinosis; Calcium; Cell Transdifferentiation; Chond

2010
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
    AIDS (London, England), 2010, Jul-17, Volume: 24, Issue:11

    Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Disease Progression; Epidemiologic Methods; Fem

2010
[Effects of compound Centella asiatica enema on kidneys coefficient, electrolytes and blood in chronic renal failure rats].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2010, Volume: 33, Issue:5

    Topics: Adenine; Animals; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Electrolytes; Er

2010
NADPH oxidase activity is associated with cardiac osteopontin and pro-collagen type I expression in uremia.
    Free radical research, 2011, Volume: 45, Issue:4

    Topics: Adenine; Animals; Blotting, Western; Cardiovascular Diseases; Catalase; Collagen Type I; Diet, Prote

2011
Motor and behavioral changes in rats with adenine-induced chronic renal failure: influence of acacia gum treatment.
    Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:1

    Topics: Adenine; Animals; Body Weight; Creatinine; Depression; Drinking; Gum Arabic; Kidney Failure, Chronic

2011
HIV-2 infection, end-stage renal disease and protease inhibitor intolerance: which salvage regimen?
    Clinical drug investigation, 2011, Volume: 31, Issue:5

    Topics: Adenine; Adult; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV-2; Humans; Kidney Fa

2011
Protection of Chinese herbs against adenine-induced chronic renal failure in rats.
    African journal of traditional, complementary, and alternative medicines : AJTCAM, 2010, Volume: 7, Issue:4

    Topics: Adenine; Albuminuria; Animals; Blood Urea Nitrogen; China; Creatinine; Drugs, Chinese Herbal; Kidney

2010
Effect of Acacia gum on blood pressure in rats with adenine-induced chronic renal failure.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2011, Oct-15, Volume: 18, Issue:13

    Topics: Acacia; Adenine; Animals; Antihypertensive Agents; Blood Pressure; Gum Arabic; Humans; Kidney Failur

2011
Vascular calcification is associated with cortical bone loss in chronic renal failure rats with and without ovariectomy: the calcification paradox.
    American journal of nephrology, 2011, Volume: 34, Issue:4

    Topics: Adenine; Animals; Aorta; Body Weight; Bone and Bones; Calcinosis; Disease Progression; Female; Kidne

2011
Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2012, Volume: 17, Issue:1

    Topics: Adenine; Animals; Biomarkers; Chromatography, Liquid; Creatinine; Kidney Failure, Chronic; Lysophosp

2012
Metanephros transplantation inhibits the progression of vascular calcification in rats with adenine-induced renal failure.
    Nephron. Experimental nephrology, 2012, Volume: 120, Issue:1

    Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Adenine; Animals; Aorta, Thoracic; Calcitriol; Calcium; Cr

2012
Effect and mechanism of fucoidan derivatives from Laminaria japonica in experimental adenine-induced chronic kidney disease.
    Journal of ethnopharmacology, 2012, Feb-15, Volume: 139, Issue:3

    Topics: Adenine; Animals; Antioxidants; Blood Urea Nitrogen; Creatinine; Kidney; Kidney Failure, Chronic; La

2012
Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS.
    Clinica chimica acta; international journal of clinical chemistry, 2012, Mar-22, Volume: 413, Issue:5-6

    Topics: Adenine; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Kidney Failure, Chro

2012
Association of tenofovir exposure with kidney disease risk in HIV infection.
    AIDS (London, England), 2012, Apr-24, Volume: 26, Issue:7

    Topics: Adenine; Adult; Anti-HIV Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infectio

2012
Vascular function in rats with adenine-induced chronic renal failure.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2012, Jun-15, Volume: 302, Issue:12

    Topics: Adenine; Animals; Aorta, Thoracic; Blood Pressure; Endothelium, Vascular; Heart Rate; Kidney Failure

2012
Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm.
    Clinica chimica acta; international journal of clinical chemistry, 2012, Oct-09, Volume: 413, Issue:19-20

    Topics: Adenine; Animals; Aspartic Acid; Cholestenones; Chromatography, High Pressure Liquid; Creatinine; Do

2012
Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS(E) data collection technique.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2012, Volume: 17, Issue:8

    Topics: Adenine; Animals; Biomarkers; Chromatography, High Pressure Liquid; Disease Models, Animal; Feces; F

2012
Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2.
    Nephron. Clinical practice, 2012, Volume: 120, Issue:4

    Topics: Adenine; Anti-HIV Agents; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Failure

2012
Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats.
    Life sciences, 2012, Dec-17, Volume: 91, Issue:25-26

    Topics: Acetaminophen; Adenine; Administration, Oral; Analgesics, Non-Narcotic; Animals; Antioxidants; Disea

2012
Comparative efficacy of three brands of gum acacia on adenine-induced chronic renal failure in rats.
    Physiological research, 2013, Volume: 62, Issue:1

    Topics: Adenine; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blood Pressure; Body Weight; D

2013
UPLC-Q-TOF/HSMS/MS(E)-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4,6,8(14),22-tetraen-3-one.
    Chemico-biological interactions, 2013, Jan-25, Volume: 201, Issue:1-3

    Topics: Adenine; Animals; Cholestenones; Chromatography, High Pressure Liquid; Discriminant Analysis; Feces;

2013
Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:3

    Topics: Adenine; Animals; Anti-Bacterial Agents; Body Weight; Gene Expression; Hypoglycemic Agents; Kidney;

2013
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
    International journal of cancer, 2013, Volume: 133, Issue:1

    Topics: Adenine; Adult; Age Factors; Aged; Aged, 80 and over; Aristolochic Acids; Carcinogens; Carcinoma, Tr

2013
Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release.
    Kidney international, 2013, Volume: 83, Issue:6

    Topics: Adenine; Alkaline Phosphatase; Amino Acid Chloromethyl Ketones; Animals; Antioxidants; Autophagy; Au

2013
Effect of gum arabic on oxidative stress and inflammation in adenine-induced chronic renal failure in rats.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Adenine; Animals; Creatinine; Gum Arabic; Histones; Immunohistochemistry; Inflammation; Interleukin-

2013
[Effects of Chinese patent medicine tongfugushen on adenine-induced chronic renal failure in rats].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 1999, Volume: 24, Issue:7

    Topics: Adenine; Animals; Drug Combinations; Drugs, Chinese Herbal; Female; Kidney Failure, Chronic; Male; P

1999
Pharmacokinetics of tenofovir in haemodialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:9

    Topics: Adenine; Anti-HIV Agents; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organophosphonates; Or

2003
Activity of (-)-epigallocatechin 3-O-gallate against oxidative stress in rats with adenine-induced renal failure.
    Journal of agricultural and food chemistry, 2004, Apr-07, Volume: 52, Issue:7

    Topics: Adenine; Animals; Antioxidants; Blood Urea Nitrogen; Catechin; Creatinine; Hydroxyl Radical; Kidney

2004
[Influence of Shenshuai Capsule on renal tissue apoptosis of rats with chronic renal failure].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2004, Volume: 27, Issue:3

    Topics: Adenine; Animals; Apoptosis; Capsules; Drug Combinations; Drugs, Chinese Herbal; fas Receptor; Kidne

2004
Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection.
    Transplantation proceedings, 2005, Volume: 37, Issue:3

    Topics: Adenine; Antiviral Agents; Creatinine; Drug Resistance, Viral; Follow-Up Studies; Hepatitis B; Human

2005
Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:7

    Topics: Adenine; Animals; Disease Models, Animal; Disease Progression; Intestinal Mucosa; Intestines; Kidney

2005
[The preparation and application of cross-linked urease aggregates].
    Sheng wu gong cheng xue bao = Chinese journal of biotechnology, 2003, Volume: 19, Issue:3

    Topics: Adenine; Animals; Enzyme Stability; Female; Glutaral; Hydrogen-Ion Concentration; Kidney Failure, Ch

2003
Enzymes that hydrolyze adenine nucleotides in chronic renal failure: relationship between hemostatic defects and renal failure severity.
    Biochimica et biophysica acta, 2005, Sep-25, Volume: 1741, Issue:3

    Topics: 5'-Nucleotidase; Adenine; Analysis of Variance; Antigens, CD; Apyrase; Blood Platelets; Creatine; Hu

2005
[Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Clinical calcium, 2005, Volume: 15 Suppl 1

    Topics: Adenine; Animals; Aortic Diseases; Calcinosis; Calcium; Disease Models, Animal; Drug Administration

2005
Effects of the Chinese herbal medicine based on Hachimi-jio-gan in male rats with the adenine-induced osteopenia.
    Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2005, Volume: 25, Issue:3

    Topics: Adenine; Animals; Bone Density; Drugs, Chinese Herbal; Kidney Failure, Chronic; Male; Osteoporosis;

2005
Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:7

    Topics: Adenine; Aged; Base Sequence; Carcinoma; Carcinoma, Renal Cell; Gene Deletion; Guanine; Humans; Kidn

2007
Chronic renal failure among HIV-1-infected patients.
    AIDS (London, England), 2007, May-31, Volume: 21, Issue:9

    Topics: Adenine; Adult; Aged; Anti-Retroviral Agents; CD4 Lymphocyte Count; Creatinine; Female; Glomerular F

2007
[Study of the Shenshuaining dispersible tablets in treating chronic renal failure rats induced by adenine].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2007, Volume: 30, Issue:4

    Topics: Adenine; Animals; Blood Urea Nitrogen; Creatinine; Drugs, Chinese Herbal; Erythrocyte Count; Female;

2007
Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:6

    Topics: Adenine; Analysis of Variance; Anemia, Iron-Deficiency; Animals; Antimicrobial Cationic Peptides; Di

2008
Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model.
    Nephrology (Carlton, Vic.), 2008, Volume: 13, Issue:2

    Topics: Adenine; Administration, Oral; Animals; Blood Urea Nitrogen; Chelating Agents; Creatinine; Diet; Dis

2008
Renal failure due to 2,8-dihydroxyadenine urolithiasis.
    European journal of pediatrics, 1982, Volume: 138, Issue:4

    Topics: Adenine; Adenine Phosphoribosyltransferase; Allopurinol; Child, Preschool; Diet, Vegetarian; Erythro

1982
[2,8-Dihydroxyadeninuria: 2.8-dihydroxyadenine crystals in urinary sediment in patients with adenine-phosphoribosyltransferase deficiency].
    Deutsche medizinische Wochenschrift (1946), 1982, Dec-10, Volume: 107, Issue:49

    Topics: Adenine; Adenine Phosphoribosyltransferase; Child, Preschool; Erythrocytes; Female; Humans; Kidney F

1982
Accelerated purine base salvage--a possible cause of elevated nucleotide pool in the erythrocytes of patients with uraemia.
    Advances in experimental medicine and biology, 1994, Volume: 370

    Topics: Adenine; Adenine Nucleotides; Adenosine; Erythrocyte Aging; Erythrocytes; Humans; Kidney Failure, Ch

1994
[Experimental study in treating chronic renal failure with dry extract and tannins of herba ephedra].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1994, Volume: 14, Issue:8

    Topics: Adenine; Animals; Drugs, Chinese Herbal; Kidney Failure, Chronic; Male; Methylguanidine; Rats; Rats,

1994
Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1994, Volume: 24, Issue:1

    Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Humans; Kidney Failure, Chronic; Kidney Transplan

1994
Reproductive insufficiency in the male rat with adenine-induced chronic renal failure.
    Urologia internationalis, 1993, Volume: 51, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Adenine; Androstenedione; Animals; Blood Urea Nitrogen; Creatinine; Fo

1993
Comparison of renal effects of creatinine, creatol and methylguanidine in rats with adenine-induced chronic renal failure.
    Nephron, 1993, Volume: 64, Issue:3

    Topics: Adenine; Animals; Creatinine; Glomerular Filtration Rate; Kidney Failure, Chronic; Kidney Function T

1993
Adenine phosphoribosyltransferase deficiency with renal deposition of 2,8-dihydroxyadenine leading to nephrolithiasis and chronic renal failure.
    Archives of internal medicine, 1993, Mar-22, Volume: 153, Issue:6

    Topics: Adenine; Adenine Phosphoribosyltransferase; Heterozygote; Humans; Kidney; Kidney Calculi; Kidney Fai

1993
[Experimental study on kidney invigorating and lipid reducing decoction-yishen jiangzhi tang in the treatment of chronic renal failure].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1993, Volume: 13, Issue:1

    Topics: Adenine; Animals; Drugs, Chinese Herbal; Female; Granuloma, Foreign-Body; Kidney; Kidney Failure, Ch

1993
Recurrence of 2,8-dihydroxyadenine tubulointerstitial lesions in a kidney transplant recipient with a primary presentation of chronic renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:4

    Topics: Adenine; Adenine Phosphoribosyltransferase; Female; Humans; Kidney Failure, Chronic; Kidney Transpla

1998
Evaluation of adenine concentration in plasma of patients with renal failure using improved ultrafiltration technique.
    Advances in experimental medicine and biology, 1998, Volume: 431

    Topics: Adenine; Adenosine; Chromatography, High Pressure Liquid; Humans; Kidney Failure, Chronic; Reference

1998
Increased rate of adenine incorporation into adenine nucleotide pool in erythrocytes of patients with chronic renal failure.
    Nephron, 2000, Volume: 86, Issue:3

    Topics: Adenine; Adenosine Triphosphate; Adult; Aged; Carbon Radioisotopes; Erythrocytes; Female; Humans; Hy

2000
Enhancement of nitroglycerin induced blood vessel relaxation in chronic renal failure model rats.
    Research communications in molecular pathology and pharmacology, 1999, Volume: 106, Issue:1-2

    Topics: Adenine; Animals; Aorta; Aryl Hydrocarbon Hydroxylases; Blood Urea Nitrogen; Cyclic GMP; Cytochrome

1999
[Adenine reutilization as a cause of increased ATP concentration in erythrocytes of patients with chronic renal failure].
    Polskie Archiwum Medycyny Wewnetrznej, 2001, Volume: 105, Issue:1

    Topics: Adenine; Adenosine Triphosphate; Adult; Aged; Erythrocytes; Female; Humans; Kidney Failure, Chronic;

2001
Clinical features and genotype of adenine phosphoribosyltransferase deficiency in iceland.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:3

    Topics: Acute Kidney Injury; Adenine; Adenine Phosphoribosyltransferase; Adolescent; Adult; Biopsy; Child; C

2001
High plasma adenine concentration in chronic renal failure and its relation to erythrocyte ATP.
    Nephron, 2002, Volume: 91, Issue:2

    Topics: Adenine; Adenosine Triphosphate; Creatinine; Erythrocytes; Female; Humans; Kidney Failure, Chronic;

2002
[Preliminary experimental and clinical study of the treatment of chronic renal insufficiency by granule of yi-qi bu-shen].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1992, Volume: 12, Issue:6

    Topics: Adenine; Adult; Animals; Blood Urea Nitrogen; Creatinine; Drugs, Chinese Herbal; Female; Humans; Kid

1992
Increase in kidney 8-hydroxydeoxyguanosine level with the progression of renal failure.
    Nephron, 1992, Volume: 61, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenine; Animals; Deoxyguanosine; DNA Damage; Free Radicals; Kidney; Ki

1992
Renal insufficiency secondary to 2,8-dihydroxyadenine urolithiasis.
    Human pathology, 1992, Volume: 23, Issue:9

    Topics: Adenine; Adenine Phosphoribosyltransferase; Crystallization; Electron Probe Microanalysis; Humans; K

1992
[Urolithiasis in chronic renal failure with hemodialysis].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50 Suppl

    Topics: Adenine; Adult; Calcium Oxalate; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Urinary Calc

1992
Potentiating effect of converting enzyme inhibitor captopril to the renal responses of magnesium lithospermate B in rats with adenine-induced renal failure.
    Chemical & pharmaceutical bulletin, 1991, Volume: 39, Issue:3

    Topics: Adenine; Animals; Captopril; Drug Synergism; Drugs, Chinese Herbal; Kidney Failure, Chronic; Male; R

1991
Degradation of adenine nucleotides in the erythrocytes of patients with chronic renal failure.
    Acta biochimica Polonica, 1990, Volume: 37, Issue:1

    Topics: Adenine; Adenine Nucleotides; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Erythrocytes; Hum

1990
The action of atriopeptin III on renal function in two models of chronic renal failure in the rat.
    British journal of pharmacology, 1990, Volume: 99, Issue:2

    Topics: Adenine; Animals; Atrial Natriuretic Factor; Diuresis; Glomerular Filtration Rate; Kidney; Kidney Fa

1990
Variations in the distribution of methylguanidine with the progression of renal failure after methylguanidine loading.
    Nephron, 1989, Volume: 52, Issue:4

    Topics: Adenine; Animals; Guanidines; Kidney Failure, Chronic; Male; Methylguanidine; Rats; Rats, Inbred Str

1989
Comparison of toxic effects of methylguanidine, guanidinosuccinic acid and creatinine in rats with adenine-induced chronic renal failure.
    Nephron, 1989, Volume: 51, Issue:3

    Topics: Adenine; Animals; Creatinine; Guanidines; Kidney Failure, Chronic; Male; Methylguanidine; Rats; Rats

1989
Urinary constituents and renal function in rats administered with adenine.
    Nihon Jinzo Gakkai shi, 1987, Volume: 29, Issue:9

    Topics: Adenine; Animals; Disease Models, Animal; Kidney; Kidney Failure, Chronic; Male; Rats

1987
Distribution of guanidino compounds in rats with chronic renal failure induced by adenine.
    Nihon Jinzo Gakkai shi, 1987, Volume: 29, Issue:9

    Topics: Adenine; Animals; Disease Models, Animal; Guanidines; Kidney Failure, Chronic; Male; Rats

1987
Blood flow in renal tissue, blood pressure, and blood hormone levels in rats with adenine-induced renal failure.
    Nihon Jinzo Gakkai shi, 1987, Volume: 29, Issue:9

    Topics: Adenine; Animals; Blood Pressure; Disease Models, Animal; Hormones; Kidney Failure, Chronic; Male; R

1987
Animal model of adenine-induced chronic renal failure in rats.
    Nephron, 1986, Volume: 44, Issue:3

    Topics: Adenine; Amino Acids; Animals; Atrophy; Creatinine; Disease Models, Animal; Fibrosis; Guanidines; Ho

1986
The uptake of glycine-14C into the adenine and guanine of DNA and insoluble RNA of human leucocytes.
    Advances in experimental medicine and biology, 1974, Volume: 41

    Topics: Adenine; Autoanalysis; Carbon Radioisotopes; Chromatography, Paper; DNA; Female; Glycine; Gout; Guan

1974